RAYMOND ROOT: Open Payments
NPI 1366290843 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $438 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $222 |
| ABBVIE INC. | 4 | $89 |
| Lilly USA, LLC | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $36 |
| Abbott Laboratories | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Wegovy, VRAYLAR, MOUNJARO, Ozempic, Quviviq, FREESTYLE LIBRE, PULMICORT, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
